Crista Prates
Adult Health · Absecon, NJNPI 1023531571
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,053 of the $8,730 with a category attached, or 92.2%. Phadia US Inc. accounts for 80.3% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $8,386, more than ten times the $111 reported in 2021. Among adult health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 41 payments — averaging $212.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phadia US Inc.$7K
- Novartis$1K
- GSK$216
- Amgen$171
- Johnson & Johnson$115
- AbbVie$49
- plus $126 from 6 others
What the payments were for
- Consulting fees$8,05392%
- Food & beverage$6778%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Phadia US Inc. | 9 | $7,013 |
| Novartis | 1 | $1,040 |
| GSK | 10 | $216 |
| Amgen | 8 | $171 |
| Johnson & Johnson | 3 | $115 |
| AbbVie | 3 | $49 |
| Boehringer Ingelheim | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Aurinia Pharma U.S., Inc. | 1 | $20 |
| AstraZeneca | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ImmunoCAP$7,013
How this compares
$8,730 in reported general payments places this provider in the 95th percentile of 1,135 adult health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 82 | $589,906 |
| OtezlaApremilast | 88 | $476,572 |
| Enbrel SureclickEtanercept | 47 | $342,475 |
| RinvoqUpadacitinib | 34 | $252,522 |
| TremfyaGuselkumab | 19 | $247,630 |
| Orencia ClickjectAbatacept | 36 | $232,077 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 21 | $168,410 |
| HumiraAdalimumab | 14 | $104,437 |
| BenlystaBelimumab | 17 | $91,958 |
| Actemra ActpenTocilizumab | 18 | $84,664 |
| Cimzia (2 Pack)Certolizumab Pegol | 11 | $62,640 |
| RasuvoMethotrexate/Pf | 63 | $46,042 |
| Hydroxychloroquine Sulfate | 465 | $20,501 |
| MethotrexateMethotrexate Sodium | 461 | $10,117 |
| Duloxetine Hcl | 140 | $3,224 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $171 | $476,57288 claims |
| AbbVieRinvoq, Humira | $49 | $356,96048 claims |
| Johnson & JohnsonTremfya | $115 | $247,63019 claims |
| GSKBenlysta | $216 | $91,95817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,135 adult health providers in New Jersey.
Other adult health in Absecon
- June HalperHackensack$358K
- Kara SaggiomoCamden$127K
- Entela AhmetiPomona$75K
- Phyllis McKiernanHackensack$72K
- Denise ForceMiddletown$71K
- Kathleen SenecaHillsborough$64K
- Diane AndresenNorthvale$60K
- Dana BeenstockFreehold$51K
- Phyllis DudaCamden$46K
- Anthony WalkoWestwood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.